
Dbpride M 1mg/500mg Tablet SR
Marketer
Pharmus Biotech
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Dbpride M 1mg/500mg Tablet SR
Metformin/Sitagliptin extended-release tablets (1mg/500mg) are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended under your doctor’s supervision.
Primary Ingredients of Dbpride M 1mg/500mg Tablet SR
There is no text provided to rephrase. Please provide the text you wish me to rewrite.
Uses of Dbpride M 1mg/500mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Dbpride M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dbpride M 1mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Dbpride M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Dbpride M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dbpride M 1mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.
How Dbpride M 1mg/500mg Tablet SR works:
Dbpride M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Dbpride M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dbpride M 1mg/500mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingUNSAFE
The extended-release combination tablet, Dbpride M (1mg/500mg), is contraindicated for use while breastfeeding due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Dbpride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. Dbpride M 1mg/500mg Tablet SR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Dbpride M 1mg/500mg SR tablets to individuals with hepatic impairment; dosage modifications may be necessary. Consult a physician for guidance. In patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Dbpride M 1mg/500mg SR tablet dosage; however, its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Dbpride M 1mg/500mg Tablet SR :
Should you forget a Dbpride M 1mg/500mg SR Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dbpride M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Medication |
